Nabota 150U
Experience Daewoong’s excellence with Nabota 150U: the purest form of botulinum toxin, prepared as a lyophilized powder ready for reconstitution. It is ideal for wrinkle reduction and anti-aging effects.
Nabota is available in 1 × 150U per vial in each package. Available in some regions.
- Packaging
- 1 × 150U vial
- Duration of effect
- 6–8 months
- Storage
- 2–8 °C, refrigerated
- Shelf life
- 36 months from the manufacturing date
About Nabota 150U
Nabota 150U was developed with Daewoong’s years of experience in biotechnology, incorporating quality international standards through its own patented manufacturing processes. The purification technology, also known as HI-PURE technology, is used to manufacture the Nabota solution, freeing it from impurities, and it is designed for various signs of aging, primarily facial wrinkles.
The quality standards set by Daewoong in developing Nabota ensure that it is safe and effective as a Botox treatment. It also demonstrates effective glabellar line reduction, making it the ideal anti-aging solution for mature skin, producing highly satisfying results. Furthermore, Nabota produces a rapid onset of action, with initial effects appearing two days after the injection.
Patients who finish treatment sessions with Nabota report being satisfied with the outcomes, which are superior to those of competing products. Patients also do not develop tolerance to Nabota after four months of treatment, even with low doses of 20 units.
Overall, Nabota significantly reduces glabellar lines and spasticity in the upper limbs. It also makes lines on the whole face look better, including the forehead, around the eyes, around the mouth and the nasolabial folds. Nabota is a good treatment for blepharospasm and hyperhidrosis of the hands and feet.
Benefits of Nabota 150U
- 01Nabota is formulated with Daewoong’s unique technology, which guarantees quality that meets worldwide standards.
- 02A highly purified product made with an innovative purification technique that gets rid of all impurities, to make sure it is safe to inject into the body.
- 03Because of its high quality, Nabota is in worldwide demand, with the export of its finished goods to about 90 countries throughout the world.
- 04Improves deep wrinkles on the face, like nasolabial folds and glabellar frown lines.
- 05Does not cause Botox resistance, even in lower doses.
- 06It also works on fine lines, including the creases that show up in the periorbital and perioral lines.
- 07Treats hyperhidrosis, notably in the palms and soles of the feet.
- 08Corrects blepharospasm, which is when the eyelids flutter or twitch involuntarily.
Product composition
- 150U of Clostridium botulinum toxin type A
- 0.5 mg human serum albumin, which works as a stabilizer
- 0.9 mg sodium chloride, which acts as a tonic adjuster
Application sites
- Deep facial wrinkles
- Glabellar frown lines
- Nasolabial folds
- Eye wrinkles (periorbital)
- Mouth lines or commissures (perioral)
- Hyperhidrosis in the palms and soles of the feet
- Blepharospasm
Duration of effect
6–8months
Generally, the initial effect is observed within 2 days after the treatment session, and the results become evident 1 to 2 weeks post-treatment. Results can last from 6 to 8 months. Moreover, to maximize the results, it is best to preserve the product’s potency and stability with proper storage.
Product specifications of Nabota 150U
Nabota 150U must be used only by medical professionals, to prevent untoward adverse reactions and achieve optimal results. Nabota reconstitution and dilution chart
- Packaging
- 1 × 150U vial
- Composition
- 150U Clostridium botulinum toxin type A, 0.5 mg stabilizer (human serum albumin), 0.9 mg tonic adjuster (sodium chloride)
- Injection depth
- Intramuscular
- Cannula size
- 27G–30G
- Application areas
- Eyelids, glabella/frown lines, calf muscles, forehead, palms and soles of the feet
- Recommended dosage
- When treating prominent glabellar lines with Nabota 150U, use a sterile 30G needle and inject a dose of 0.1 mL into each of the five injection sites: 2 injection points in each corrugator muscle and 1 injection point in the procerus muscle, for a total dose of 20 units.
- Treatment interval
- Maintenance treatment sessions no sooner than 3 months after the initial procedure. Avoid frequent treatment sessions, to prevent tolerance to the product and overdosage.
- Duration of effect
- 6–8 months
- Storage
- Store at 2–8 °C, refrigerated, in its hermetic container
- Shelf life
- 36 months from the manufacturing date
- Manufacturer
- Daewoong Pharmaceutical Co., Ltd.
Order Nabota through Nabota USA
Request pricing or send a purchasing inquiry for Nabota 150U, or ask about availability, specifications and professional-use information.